3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Glioblastoma
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Esophageal Neoplasms
2
Rhabdomyosarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Neurofibromatosis 1
1
Meningioma
1
Lymphoma
1
Lung Neoplasms
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Adrenocortical Carcinoma
1
Interventions
venetoclax
1
tegafur-gimeracil-oteracil
1
tagraxofusp
1
Surgical Procedures, Operative
1
Radiation
1
Oxaliplatin
1
Observation
1
Neoadjuvant Therapy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Irinotecan
1
Induction Chemotherapy
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Folfox protocol
1
Fluorouracil
1
FOLFOXIRI protocol
1
Endoscopy
1
Drug Therapy
1
Colonoscopy
1
Chemoradiotherapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Pathologic Complete Response
×
Radiation
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled